mafosfamide has been researched along with acrolein in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Farquhar, D; Wang, YQ | 1 |
Bear, HD; Bethke, KP; Frank, JL; Hoover, SK; Inge, TH; Kawabata, TT | 1 |
Blomgren, H; Hallström, M | 1 |
3 other study(ies) available for mafosfamide and acrolein
Article | Year |
---|---|
Aldophosphamide acetal diacetate and structural analogues: synthesis and cytotoxicity studies.
Topics: Animals; Antineoplastic Agents; Carboxylesterase; Carboxylic Ester Hydrolases; Cell Survival; Drug Screening Assays, Antitumor; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Phosphoramide Mustards; Prodrugs; Structure-Activity Relationship | 1991 |
Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamide.
Topics: Acrolein; Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cell Division; Cells, Cultured; Cyclophosphamide; Immunotherapy, Adoptive; Mast-Cell Sarcoma; Mice; Mice, Inbred DBA; Spleen; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory | 1992 |
Possible role of acrolein in oxazaphosphorine-induced enhancement of immunological reactivity.
Topics: Acrolein; Aldehydes; Antineoplastic Agents; Concanavalin A; Cyclophosphamide; Humans; Immunity, Cellular; Lymphocytes; Mitogens; Mitosis; T-Lymphocytes; T-Lymphocytes, Regulatory | 1990 |